CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 84 enrolled
Drug / intervention
Acupuncture +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03783546
NCT03783546N/ACompleted

Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial

Dana-Farber Cancer Institute·interventional·Posted Dec 21, 2018·Updated Mar 9, 2026

In Brief

A clinical study evaluating Acupuncture and Usual Care for Breast Cancer. Completed, enrolled 84 participants across 1 site.

Detailed Summary

This research study is evaluating acupuncture, a medical therapy in which hair-thin, stainless steel needles are shallowly inserted into specific points to help the body's natural healing process, as a possible treatment to reduce hot flashes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 21, 2018
Enrollment StartJan 15, 2019
Primary CompletionJan 31, 2022
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 7.5 years ago

Interventions

Acupuncturedevice

Acupuncture is a complementary therapy in which, hair-thin, sterile disposable needles are inserted into various spots on your skin, with the goal of affecting body's natural healing system

Usual Careother

the current standard of care with non-hormonal pharmacotherapy of western medicine